• Something wrong with this record ?

Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations

J. Tužil, J. Matějka, MA. Mamas, T. Doležal

. 2023 ; 21 (4) : 293-304. [pub] 20230307

Language English Country England, Great Britain

Document type Systematic Review, Meta-Analysis, Journal Article

OBJECTIVES: To verify whether transradial (TRA) compared to transfemoral (TFA) cardiac catheterization reduces the risk of periprocedural stroke (PS). METHODS: We reviewed (CRD42021277918) published real-world cohorts reporting the incidence of PS within 3 days following diagnostic or interventional catheterization. Meta-analyses and meta-regressions of odds ratios (OR) performed using the DerSimonian and Laird method were checked for publication bias (Egger test) and adjusted for false-positive results (study sequential analysis SSA). RESULTS: The pooled incidence of PS from 2,188,047 catheterizations (14 cohorts), was 193 (105 to 355) per 100,000. Meta-analyses of adjusted estimates (OR = 0.66 (0.49 to 0.89); p = 0.007; I2 = 90%), unadjusted estimates (OR = 0.63 (0.51 to 0.77; I2 = 74%; p = 0.000)), and a sub-group of prospective cohorts (OR = 0.67 (0.48 to 0.94; p = 0.022; I2 = 16%)) had a lower risk of PS in TRA (without indication of publication bias). SSA confirmed the pooled sample size was sufficient to support these conclusions. Meta-regression decreased the unexplained heterogeneity but did not identify any independent predictor of PS nor any effect modifier. CONCLUSION: Periprocedural stroke remains a rare and hard-to-predict adverse event associated with cardiac catheterization. TRA is associated with a 20% to 30% lower risk of PS in real-world/common practice settings. Future studies are unlikely to change our conclusion.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010541
003      
CZ-PrNML
005      
20230801132504.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/14779072.2023.2187378 $2 doi
035    __
$a (PubMed)36877129
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tužil, Jan $u Value Outcomes s.r.o., Prague, Czech Republic $u Biomedical informatics, First Medical Faculty, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000271824010
245    10
$a Short-term risk of periprocedural stroke relative to radial vs. femoral access: systematic review, meta-analysis, study sequential analysis and meta-regression of 2,188,047 real-world cardiac catheterizations / $c J. Tužil, J. Matějka, MA. Mamas, T. Doležal
520    9_
$a OBJECTIVES: To verify whether transradial (TRA) compared to transfemoral (TFA) cardiac catheterization reduces the risk of periprocedural stroke (PS). METHODS: We reviewed (CRD42021277918) published real-world cohorts reporting the incidence of PS within 3 days following diagnostic or interventional catheterization. Meta-analyses and meta-regressions of odds ratios (OR) performed using the DerSimonian and Laird method were checked for publication bias (Egger test) and adjusted for false-positive results (study sequential analysis SSA). RESULTS: The pooled incidence of PS from 2,188,047 catheterizations (14 cohorts), was 193 (105 to 355) per 100,000. Meta-analyses of adjusted estimates (OR = 0.66 (0.49 to 0.89); p = 0.007; I2 = 90%), unadjusted estimates (OR = 0.63 (0.51 to 0.77; I2 = 74%; p = 0.000)), and a sub-group of prospective cohorts (OR = 0.67 (0.48 to 0.94; p = 0.022; I2 = 16%)) had a lower risk of PS in TRA (without indication of publication bias). SSA confirmed the pooled sample size was sufficient to support these conclusions. Meta-regression decreased the unexplained heterogeneity but did not identify any independent predictor of PS nor any effect modifier. CONCLUSION: Periprocedural stroke remains a rare and hard-to-predict adverse event associated with cardiac catheterization. TRA is associated with a 20% to 30% lower risk of PS in real-world/common practice settings. Future studies are unlikely to change our conclusion.
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    12
$a koronární angioplastika $x metody $7 D062645
650    12
$a cévní mozková příhoda $x epidemiologie $x etiologie $x prevence a kontrola $7 D020521
650    _2
$a srdeční katetrizace $x škodlivé účinky $x metody $7 D006328
650    _2
$a arteria radialis $7 D017534
650    _2
$a arteria femoralis $7 D005263
650    _2
$a výsledek terapie $7 D016896
650    12
$a periferní katetrizace $x metody $7 D002406
650    _2
$a rizikové faktory $7 D012307
655    _2
$a systematický přehled $7 D000078182
655    _2
$a metaanalýza $7 D017418
655    _2
$a časopisecké články $7 D016428
700    1_
$a Matějka, Jan $u Department of Cardiology, Hospital of Pardubice, Pardubice, Czech Republic $u Faculty of Health Studies, University of Pardubice, Pardubice, Czech Republic $u Academic Department of Internal Medicine, Charles University Faculty of Medicine, Hradec Králové, Czech Republic
700    1_
$a Mamas, Mamas A $u Keele Cardiovascular Research Group, University of Keele, StokeonTrent, UK $1 https://orcid.org/0000000192418890
700    1_
$a Doležal, Tomáš $u Value Outcomes s.r.o., Prague, Czech Republic $u Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00174406 $t Expert review of cardiovascular therapy $x 1744-8344 $g Roč. 21, č. 4 (2023), s. 293-304
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36877129 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132500 $b ABA008
999    __
$a ok $b bmc $g 1963143 $s 1196806
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 21 $c 4 $d 293-304 $e 20230307 $i 1744-8344 $m Expert review of cardiovascular therapy $n Expert Rev Cardiovasc Ther $x MED00174406
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...